PHARMASCROLL
enquiry@pharmascroll.com Mail Us
  • Home
  • About Us
    • Mission and Vision
    • Our Team
    • Why PharmaScroll
  • Business Intelligence
    • TreasureTell
  • Social Media Analytics
    • SocialBI
  • Market Research Services
  • Newsroom
    • Blog
    • Podcast
    • Press Release
    • Recent News
      • Neuroscience
        • Migraine
        • Multiple Sclerosis
        • Alzheimer’s
        • Parkinson’s
        • Epilepsy
        • Schizophrenia
        • Depression
        • ADHD
      • Respiratory
        • COPD
        • Asthma
        • Pulmonary Fibrosis
        • Cystic fibrosis
        • Rhinitis
      • Oncology
      • Diabetes
  • Careers
  • Contact Us
PHARMASCROLL
  • Home
  • About Us
    • Mission and Vision
    • Our Team
    • Why PharmaScroll
  • Business Intelligence
    • TreasureTell
  • Social Media Analytics
    • SocialBI
  • Market Research Services
  • Newsroom
    • Blog
    • Podcast
    • Press Release
    • Recent News
      • Neuroscience
        • Migraine
        • Multiple Sclerosis
        • Alzheimer’s
        • Parkinson’s
        • Epilepsy
        • Schizophrenia
        • Depression
        • ADHD
      • Respiratory
        • COPD
        • Asthma
        • Pulmonary Fibrosis
        • Cystic fibrosis
        • Rhinitis
      • Oncology
      • Diabetes
  • Careers
  • Contact Us
enquiry@pharmascroll.com Mail Us
HomeNewsNeuroscienceAlzheimer's
  • AARP Invests $60 Million for Cures to Dementia and Alzheimer’s research

    • June 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Herpesvirus may cause Alzheimer’s and also lead to its progression, study finds

    • June 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Researchers discover breakthrough in delaying Alzheimer’s progression

    • June 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Another Alzheimer’s drug by Lilly & AstraZeneca fails clinical trials

    • June 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Alzheimer’s effects reversed in Mice with an Asthma drug

    • June 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Scientists discover the role of genes in Alzheimer’s Disease

    • June 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • Alzheimer’s drug by Cortexyme receives $76m fund for Ph 2 clinical research

    • May 31, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • J&J stops trial of BACE for Alzheimer’s disease to enter the list of failed drugs

    • May 19, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • New Alzheimer’s risk genes identified through Big data research

    • May 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • EIP pharma secures $20.5m funding for Alzheimer’s drug trial

    • May 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • 1
  • 2
  • 3
  • 4
Recent Posts
  • Unlocking the Benefits of SocialBI for Patient Engagement
  • Predictive Analytics in Healthcare
  • Business Intelligence and Analytics in the Pharma Industry
  • Role of Patient Insights in Building Strong Healthcare
  • Social Media Analytics in Healthcare

Contact Us

  • Indian Address: PharmaScroll Research and Consulting Private Limited, 91 Springboard, 4th floor, F948+W7, Laxmi Cyber City, Whitefields, Hyderabad, Telangana 500081
  • US address: 12 Self Ct, Wallingford CT 06492
  • +919311760222
  • enquiry@pharmascroll.com

Recent Tweets

Could not authenticate you.

Recent Posts

  • Unlocking the Benefits of SocialBI for Patient Engagement
  • Predictive Analytics in Healthcare
  • Business Intelligence and Analytics in the Pharma Industry

News Letter

© 2025 Copyright. All rights reserved